APRECAP INJ

APRECAP INJ 150mg is a prescription medication used to prevent nausea and vomiting associated with chemotherapy and other anti-cancer treatments. It is an intravenous injection that contains fosaprepitant, a medication that works by blocking the action of serotonin and other neurotransmitters in the brain.

Composition:

Each vial of APRECAP INJ 150mg contains 150mg of fosaprepitant dimeglumine.

Mechanism of Action:

Fosaprepitant works by blocking the action of serotonin and other neurotransmitters in the brain, which helps to prevent nausea and vomiting. It does this by binding to serotonin receptors in the brain, which reduces the activity of serotonin and other neurotransmitters that can contribute to nausea and vomiting.

Uses:

APRECAP INJ 150mg is used to prevent:

• Nausea and vomiting caused by chemotherapy
• Nausea and vomiting caused by radiation therapy
• Nausea and vomiting caused by other anti-cancer treatments

Dosage:

The recommended dosage of APRECAP INJ 150mg is:

• 150mg administered as an intravenous injection over 10-15 minutes
• Given as a single dose, 30 minutes prior to chemotherapy or other anti-cancer treatment

Side Effects:

Common side effects of APRECAP INJ 150mg include:

• Nausea
• Vomiting
• Headache
• Fatigue
• Dizziness
• Constipation
• Diarrhea

Recommendation:

APRECAP INJ 150mg is recommended for patients who are at high risk of developing nausea and vomiting due to chemotherapy or other anti-cancer treatments. Patients should also be advised to drink plenty of water and eat small, frequent meals during chemotherapy to help reduce the risk of nausea and vomiting.

Important Note:

Patients should not take APRECAP INJ 150mg if they have a history of severe allergic reactions, liver problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or seizure disorders, before taking APRECAP INJ 150mg.